# Jeff Round

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeff-round/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,707 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 27 |
| i10-index | 50 |
| Last Known Institution | University of Alberta |
| OpenAlex ID | https://openalex.org/A5048785509 |
| ORCID iD | 0000-0002-3103-6984 |
| Works | 143 |

## Researcher papers

- [ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update](https://scholariq.org/papers/isscr-guidelines-for-stem-cell-research-and-clinical-translation-the-2021-update/)
- [Lancet Commission: Stem cells and regenerative medicine](https://scholariq.org/papers/lancet-commission-stem-cells-and-regenerative-medicine/)
- [Behavioural and psychiatric symptoms in people with dementia admitted to the acute hospital: prospective cohort study](https://scholariq.org/papers/behavioural-and-psychiatric-symptoms-in-people-with-dementia-admitted-to-the/)
- [A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease](https://scholariq.org/papers/a-systematic-review-and-economic-evaluation-of-the-use-of-tumour-necrosis-factor/)
- [An Educational Review of the Statistical Issues in Analysing Utility Data for Cost-Utility Analysis](https://scholariq.org/papers/an-educational-review-of-the-statistical-issues-in-analysing-utility-data-for/)
- [Estimating the cost of caring for people with cancer at the end of life: A modelling study](https://scholariq.org/papers/estimating-the-cost-of-caring-for-people-with-cancer-at-the-end-of-life-a/)
- [Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)](https://scholariq.org/papers/mirtazapine-added-to-ssris-or-snris-for-treatment-resistant-depression-in/)
- [An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England](https://scholariq.org/papers/an-early-evaluation-of-clinical-and-economic-costs-and-benefits-of-implementing/)
- [Is a QALY still a QALY at the end of life?](https://scholariq.org/papers/is-a-qaly-still-a-qaly-at-the-end-of-life/)
- [Rehabilitation in Advanced, Progressive, Recurrent Cancer: A Randomized Controlled Trial](https://scholariq.org/papers/rehabilitation-in-advanced-progressive-recurrent-cancer-a-randomized-controlled/)
- [A systematic review of the accessibility, acceptability, safety, efficiency, clinical effectiveness, and cost-effectiveness of private cataract and orthopedic surgery clinics](https://scholariq.org/papers/a-systematic-review-of-the-accessibility-acceptability-safety-efficiency/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)
- [Healthcare cost, quality, practices](https://scholariq.org/topics/healthcare-cost-quality-practices/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)

## Researcher university

- [University of Alberta](https://scholariq.org/institutions/university-of-alberta/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.